Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (11-20 of 372) with videos related to

Pageof 38
Sort By:
Best Practice & Research. Clinical Obstetrics & Gynaecology|November 5, 2002
Molecular aspects of ovarian cancerRobert M Wenham, Johnathan M Lancaster, Andrew Berchuck
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Response to Weidhaas and Slack re: Comments on "The role of <i>KRAS</i> rs61764370 in invasive epithelial ovarian cancer: implication for clinical testing"Harvey A Risch, Andrew Berchuck, Paul D P Pharoah
Gynecologic Oncology Reports|June 16, 2015
Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic typeAndrew Berchuck, Leora Witkowski, Martin Hasselblatt, et al.
Gynecologic Oncology|June 25, 2003
Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controlsMarilyn F Vine, Brian Calingaert, Andrew Berchuck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?Andrew Berchuck, Angeles Alvarez Secord, Haley A Moss, et al.
Gynecologic Oncology|December 2, 2017
Urinary diversion in the genitourinary cancer survivorOmari K Johnson, Andrew Berchuck, Angeles A Secord, et al.
Annals of the New York Academy of Sciences|May 2, 2003
Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancersJohn I Risinger, G Larry Maxwell, Andrew Berchuck, et al.
Plos Genetics|June 30, 2018
The importance of using public data to validate reported associationsGeorgia Chenevix-Trench, Jonathan Beesley, Paul D P Pharoah, et al.
American Journal of Obstetrics and Gynecology|July 16, 2005
Menopausal hormones and risk of ovarian cancerPatricia G Moorman, Joellen M Schildkraut, Brian Calingaert, et al.
Obstetrics and Gynecology|April 2, 2005
Antidepressant medication use [corrected] and risk of ovarian cancerPatricia G Moorman, Andrew Berchuck, Brian Calingaert, et al.
Pageof 38

Showing results (11-20 of 372) with videos related to

Sort By:
Pageof 38
Best Practice & Research. Clinical Obstetrics & Gynaecology|November 5, 2002
Molecular aspects of ovarian cancerRobert M Wenham, Johnathan M Lancaster, Andrew Berchuck
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Response to Weidhaas and Slack re: Comments on "The role of <i>KRAS</i> rs61764370 in invasive epithelial ovarian cancer: implication for clinical testing"Harvey A Risch, Andrew Berchuck, Paul D P Pharoah
Gynecologic Oncology Reports|June 16, 2015
Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic typeAndrew Berchuck, Leora Witkowski, Martin Hasselblatt, et al.
Gynecologic Oncology|June 25, 2003
Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controlsMarilyn F Vine, Brian Calingaert, Andrew Berchuck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?Andrew Berchuck, Angeles Alvarez Secord, Haley A Moss, et al.
Gynecologic Oncology|December 2, 2017
Urinary diversion in the genitourinary cancer survivorOmari K Johnson, Andrew Berchuck, Angeles A Secord, et al.
Annals of the New York Academy of Sciences|May 2, 2003
Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancersJohn I Risinger, G Larry Maxwell, Andrew Berchuck, et al.
Plos Genetics|June 30, 2018
The importance of using public data to validate reported associationsGeorgia Chenevix-Trench, Jonathan Beesley, Paul D P Pharoah, et al.
American Journal of Obstetrics and Gynecology|July 16, 2005
Menopausal hormones and risk of ovarian cancerPatricia G Moorman, Joellen M Schildkraut, Brian Calingaert, et al.
Obstetrics and Gynecology|April 2, 2005
Antidepressant medication use [corrected] and risk of ovarian cancerPatricia G Moorman, Andrew Berchuck, Brian Calingaert, et al.
Pageof 38